Encapsula NanoSciences LLC

Encapsula NanoSciences LLC is a privately held nanotechnology research and development company located in Brentwood, Tennessee. Employing 5-9 individuals, the company boasts a revenue stream of $2.5 million. Encapsula NanoSciences specializes in the formulation and manufacturing of various liposomes, serving a diverse clientele across five continents. Their offerings include Clodronate liposomes, control liposomes, Doxorubicin liposomes, surface active liposomes, DNA and RNA liposomes, fluorescent liposomes, freeze-dried liposome kits, and liposomes designed as artificial cell models. Additionally, they provide liposomal formulations for nutritional supplements, enhancing the bioavailability of poorly fat-soluble molecules like Curcumin. Their proprietary Curcusome® formulation combines liposomal Curcumin with Piperine and Quercetin, packaged as a freeze-dried product that forms highly bioavailable liposomes upon reconstitution. Beyond manufacturing, Encapsula NanoSciences offers comprehensive solutions encompassing development, contract research, and patent due diligence services. The company actively collaborates with academic research laboratories, particularly focusing on developing novel anti-tumor compounds utilizing liposomal delivery systems. Their expertise extends to the food technology industry, exploring the potential of lipid-based antimicrobials to address food safety concerns. Interested parties can connect with Encapsula NanoSciences via their website at encapsula.com.